Overview
- The Ministry of Health renewed Cordlife’s cord blood banking service licence from Jan 14, 2026 to Jan 13, 2027, while continuing the prohibition on collecting, testing, processing and storing new units imposed since Nov 26, 2025.
- The renewed permit allows storage and transfer of existing cord blood units, retrieval for clinical use such as transplants, and disposal at clients’ request, including transfers to other accredited providers.
- Cordlife’s human tissue banking service licence was also renewed for two years, extending that approval through 2028.
- Cordlife applied on Jan 13 to convert parents’ claims of at least $5.45 million over 109 units into an originating claim, with an affidavit due from claimants by Feb 3 and a warning from the company that any payout this financial year would hurt its finances.
- The company’s shares jumped more than 18 percent after the announcement, rising to S$0.15 in morning trade.